Skip to content
Page Path 'Breadcrumb':
Presentations
Annual European Congress of Rheumatology EULAR 2010
Efficacy and Safety of a Range of Doses of RDEA594, a Novel Uricosuric Agent, as a Single Agent in Hyperuricemic Gout Patients: Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Experience
RDEA684, a Novel, Potent and Efficacious Inhibitor of Human Urate Transporter, URAT1, with a Favorable Pharmacokinetic Profile, and No Mitochondrial Toxicity
48th Annual ICAAC/IDSA 46th Annual Meeting
RDEA806, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Shows Positive Outcome in Treatment Naïve HIV Patients
2008 ACR/ARHP Annual Scientific Meeting
MEK Inhibitor RDEA119 Suppresses Inflammatory Cytokine Production Induced by Monosodium Urate Crystals
XVII International AIDS Conference
Antiviral activity of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor, in treatment of naive HIV patients
Digestive Disease Week 2008
RDEA119, A Potent and Highly Selective MEK Inhibitor Ameliorates Murine Colitis